NUTEX HEALTH INC

NASDAQ: NUTX (Nutex Health Inc.)

最近更新时间: 4天之前, 3:43PM

174.51

4.81 (2.83%)

前收盘价格 169.70
成交量 175,126
价格/销量 (P/S) 1.53
股市价格/股市净资产 (P/B) 2.73
52周波幅
83.99 (-51%) — 226.16 (29%)
营业毛利率 10.76%
营业利益率 (TTM) 34.10%
稀释每股收益 (EPS TTM) 12.35
季度收入增长率 (YOY) 214.00%
总债务/股东权益 (D/E MRQ) 124.19%
流动比率 (MRQ) 2.27
营业现金流 (OCF TTM) 71.07 M
杠杆自由现金流 (LFCF TTM) 46.11 M
资产报酬率 (ROA TTM) 22.34%
股东权益报酬率 (ROE TTM) 78.92%

AIStockmoo 评分

1.1
当前股价隐含每年 -1.9% 的盈利增长;公司业务可支撑约每年 15.0% 的增长。因近年曾亏损,计入较少。 参考
资本回报远高于资本成本。资本回报上升。 参考
负债高。盈利能力强。短期流动性充足。现金流为正。 参考
来自我们的 AI Insight 报告对预期回报与风险的评估。 参考 NA
相对估值 参考 NA
历史估值 参考 NA
持仓估值 参考 NA
风险溢价 参考 NA
市场估值 参考 NA
过去一年呈上升趋势。股价略低于52周高点。 参考
趋势不明:股价在均线附近徘徊。股价接近均线。下跌日成交量较大。 参考
来自我们对走势图的 AI 技术分析。 参考 NA
K线形态 参考 NA
近期没有目标价,因此依据目标价的调整方向。 参考
近期新闻好坏参半或中性。 参考
持仓情绪 参考 NA
机构在最新13F申报中净+6.86%的股份:119家增持,65家减持(截至30 Sep 2026的季度)。 参考
空头持仓从31 Aug到30 Oct 2026变化+0.2%,回补天数10.1天(FINRA)。 参考
内部交易活动 参考 NA
市场环境偏谨慎。 参考
行业表现优于大市。
各支柱方向一致,评分因此加强。
每股盈利有升有降。近年曾亏损。 参考
低于中期趋势线。 参考
股价高于其52周平均水平。5年来下跌。 参考
短期动能下降。 参考
股价接近阻力位。支撑与阻力水平趋降。 参考
最终评分 1.09
全部展开

市场趋势

短期 中期
行业 Medical Care Facilities (US) 混合的 混合的
Medical Care Facilities (全球的) 看涨 混合的
股票 Nutex Health Inc. 混合的 混合的

相关股票

股票 市值 DY P/E(TTM) P/B 评分
NUTX - - - 2.73 1.1
ENSG 10 B 0.15% 26.24 4.17 -0.5
SGRY 3 B - - 2.12 1.9
PNTG 1 B - 34.30 3.34 -1.9
LFST - - - 3.59 1.4
INNV - - - 5.03 -1.1

Nutex Health Inc is healthcare services and operations company with 20 hospital facilities in eight states (hospital division), and a primary care-centric, risk-bearing population health management division. The hospital division implements and operates healthcare models, including micro-hospitals, specialty hospitals and hospital outpatient departments (HOPDs). The population health management division owns and operates provider networks such as independent physician associations (IPAs) and offers a cloud-based proprietary technology platform to IPAs that aggregates clinical and claims data across multiple settings, information systems and sources to create a holistic view of patients and providers.

部门 Healthcare
行业 Medical Care Facilities
投资方式 Small Growth
内部持股比例 35.81%
机构持股比例 21.20%

该时间范围内无数据。

该时间范围内无数据。

机构

机构持股比例: 50.82%

持仓变动 机构数 股数
增持 119 629,065
减持 65 295,626
新建仓 51 225,662
清仓 13 78,773

来源:经Nasdaq的SEC 13F申报,最新申报截至30 Sep 2026。申报在每季结束后45天内陆续提交。

空头持仓

结算日 股数 回补天数
30 Oct 2026 1,164,595 10.1
15 Oct 2026 1,237,099 7.6
30 Sep 2026 1,250,508 8.2
15 Sep 2026 1,234,054 7.5
31 Aug 2026 1,162,501 8.6
14 Aug 2026 1,130,121 5.8

来源:经Nasdaq的FINRA空头持仓数据,每月公布两次。

2 正面 2 负面 6 中性
日期 类型 细节
17 Nov 2026 Yahoo Finance Nutex Health Declares First Dividend as a Public Company
Nutex Health Inc. ("Nutex Health" or the "Company") (Nasdaq Global Market and Nasdaq Texas: NUTX), today announced that its Board of Directors (the "Board"), acting by unanimous approval of its independent directors, has declared a special cash dividend of $2.00 per share of the Company's common…
12 Nov 2026 Yahoo Finance Nutex Health Inc (NUTX) (Q3 2026) Earnings Call Highlights: Net Income Jumps 159% Despite ...
Nutex Health Inc (NUTX) posted strong profit growth and a 10.2% rise in patient visits in the first nine months of 2026, even as total revenue fell 11% and adjusted EBITDA slipped 13%.
09 Nov 2026 Yahoo Finance NUTX Q3 Earnings Call Highlights Reimbursement and Hospital Growth
Nutex Health's Q3 2026 earnings call highlights rising hospital visits, stable arbitration collections and expansion plans despite an 18.7% revenue decline.
07 Nov 2026 Yahoo Finance Nutex Health (NUTX) Q3 2026 Earnings Call Transcript
Revenue slipped, but net income surged as compensation costs fell sharply.
06 Nov 2026 Yahoo Finance Nutex Health Q3 Earnings Call Highlights
Nutex Health (NASDAQ:NUTX) reported lower third-quarter revenue and earnings despite a rise in hospital visits, as executives pointed to prior-year revenue adjustments tied to collections under the federal independent dispute resolution process. Revenue fell to $217.6 million in the third quarter o…
06 Nov 2026 Yahoo Finance Can Nutex Health (NUTX) Keep Looking Cheap After 4x Gains?
Nutex Health has delivered very strong share gains over the past three years, yet recent pullbacks have put the spotlight back on a basic question for investors who care about valuation: Is the current price still in line with what the company is earning today? The stock is up about 4x over the…
06 Nov 2026 Yahoo Finance Nutex Health, Inc. Q3 2026 Earnings Call Summary
Moby summary of Nutex Health, Inc.'s Q3 2026 earnings call…
05 Nov 2026 Yahoo Finance Nutex Health Inc. (NUTX) Q3 Earnings and Revenues Beat Estimates
Nutex Health (NUTX) delivered earnings and revenue surprises of +3.26% and +0.33%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
05 Nov 2026 Yahoo Finance NUTEX HEALTH REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS
Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ and Nasdaq Texas: NUTX), today announced financial results for the three and nine months ended September 30, 2026. Nutex Health is a physician-led, healthcare services and operations company with 28 hospital facilities in 12 states…
04 Nov 2026 Yahoo Finance Nutex Health Q3 Earnings: Can Cost Savings Offset Revenue Risks?
Nutex Health's Q3 earnings face revenue pressure from reimbursement uncertainty, but rising patient volumes and lower arbitration costs may support profitability.
19 Oct 2026 Yahoo Finance Nutex Health Schedules 2026 Third Quarter Financial Results Release and Conference Call
Nutex Health, Inc. (NASDAQ: NUTX), a physician-led, integrated healthcare delivery system comprised of 28 state-of-the-art micro hospitals and hospital outpatient departments in 12 states and primary care-centric, risk-bearing physician networks, today announced that it plans to file its Form 10-Q…
08 Oct 2026 Yahoo Finance 2 Stocks to Buy Hand Over Fist in October
Nutex Health and Elevance Health may be underpriced, despite their share growth this year.
05 Oct 2026 Yahoo Finance 5 Stocks With Recent Price Strength After a Mixed September
Five stocks showing recent price strength include VNCE, VRA, AOUT, NUTX and FET, with strong momentum and improving earnings estimates.
01 Oct 2026 Yahoo Finance Bet on These 4 Stocks With Strong Net Profit Margins to Boost Returns
Let's take a look at four stocks, NUTX, RCMT, TILE and QUAD, with impressive net profit margins for a robust portfolio.
28 Sep 2026 Yahoo Finance Here's What Could Help Nutex Health (NUTX) Maintain Its Recent Price Strength
Nutex Health (NUTX) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.
24 Sep 2026 Yahoo Finance Can Nutex Health (NUTX) Stay Undervalued As Earnings Shift?
Nutex Health has become a high profile healthcare stock after a very large 3 year return, and the question now is whether that market price lines up with what the business is earning. With the move influenced by both operational progress and fresh risks, the key issue for anyone looking at Nutex…
24 Sep 2026 Yahoo Finance Nutex Health (NUTX) Could Be 29% Undervalued As Nasdaq Texas Listing Nears
Nutex Health (NUTX) just secured approval to dual-list its common stock on Nasdaq Texas, with trading expected to begin around September 23, 2026. This move may broaden liquidity and investor access. Recent trading has been choppy for Nutex Health, with the share price slipping 3.33% over the last…
22 Sep 2026 Yahoo Finance Nutex Health Approved for Dual Listing on Nasdaq Texas
Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX) today announced that it has received approval to dual-list its common stock on Nasdaq Texas. Nutex Health is a physician-led, healthcare services and operations company with 28 hospital facilities in 12 states, and a primary…
18 Sep 2026 Yahoo Finance Zacks.com featured highlights EuroDry, Vince Holding, Nutex, TXO Partners and KB Financial
EuroDry, Vince Holding, Nutex, TXO Partners and KB Financial have been highlighted in this Screen of The Week article.
17 Sep 2026 Yahoo Finance 5 Stocks With Recent Price Strength Amid a Volatile September
EDRY, VNCE, NUTX, TXO and KB show strong recent price momentum despite a volatile September, backed by improving earnings expectations.
显示更多

近期信号 K线形态与EMA交叉

▼ EMA看跌交叉 4个交易日前 · 11 Nov
中期 · EMA 20/50
20日EMA下穿50日EMA:中期趋势转为向下。

技术形态 中期

趋势排列
斜率
入场位置
成交量
趋势不明:股价在均线附近徘徊。股价接近均线。下跌日成交量较大。
最近支撑: 166.72 – 186.18 · 强 · 多次测试,可能失守
最近阻力: 180.72 – 191.27 · 强

AI 技术分析

投资组合

AI 建议策略模板

自定义的价格提醒

风险概况

| | | | |
很保守
适度保守
中等
中等风险
激进风险
安全边际 (EP)
部分利润 (TP1)
目标利润 (TP2)
最大损失 (SL)

免责声明:以上内容仅供参考,并非投资建议。请咨询合格的财务顾问。

开始购买价格 (EP)

第一个目标价格赚取利润 (TP1)

第二个目标价格赚取利润 (TP2)

停止损失价格 (SL)

风险 / 回报
TP1:
TP2:

以入场价计算,止损的亏损相对每个目标价的盈利。通常追求 2 或以上的比率。

52周波幅范围
 
52WL
 
52WH
SL
EP
TP1
TP2

所有提醒价格都在52周波幅范围内

已实现利润 -
未实现利润 -
收到股息 2026 -
利润总额 -
平均回报 -
数量(购买) -
平均价格(购买) -
数量(卖出) -
平均价格(卖出) -
没有符合您标准的股票